Stay updated on Phase 2a Safety of MEDI8852 in Influenza Clinical Trial
Sign up to get notified when there's something new on the Phase 2a Safety of MEDI8852 in Influenza Clinical Trial page.

Latest updates to the Phase 2a Safety of MEDI8852 in Influenza Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page's software revision label was updated from v3.6.4 to v3.6.5. This indicates a newer release of the page's underlying system rather than any substantive update to the study information.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedFooter revision label updated from Revision: v3.6.3 to Revision: v3.6.4, representing a minor update to the page's versioning metadata.SummaryDifference0.0%

- Check54 days agoChange DetectedThe footer now displays Revision: v3.6.3, replacing the previous v3.6.2, indicating a platform update. This reflects a software version change rather than a modification to study data or navigation elements.SummaryDifference0.0%

- Check61 days agoChange DetectedThe page footer updated from revision v3.6.0 to v3.6.2. This reflects a small platform/template update rather than a substantive change to the study details.SummaryDifference0.0%

- Check75 days agoChange DetectedRecruitment status updated to 'No longer looking for participants,' indicating that participant enrollment is closed. Added user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and updated the footer to Revision: v3.6.0, while replacing the label 'Intervention / Treatment' with 'Intervention/Treatment' and removing the previous revision 'v3.5.5'.SummaryDifference0.3%

- Check83 days agoChange DetectedThe page revision indicator changed from v3.5.4 to v3.5.5. This appears to be a small internal update and does not modify the study information shown.SummaryDifference0.0%

Stay in the know with updates to Phase 2a Safety of MEDI8852 in Influenza Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 2a Safety of MEDI8852 in Influenza Clinical Trial page.